Tirzepatide Pharma Peptide Lab - Your Premier Partner for Compounded Peptides and Research Solutions

Exclusive Private Label Opportunity for Small Pharmaceutical Businesses

Are you ready to expand your product portfolio with cutting-edge GLP-1 and dual receptor agonist peptides? Tirzepatide Pharma offers FDA-registered peptide solutions with B12 API enhancement, specifically designed for small pharmaceutical businesses seeking competitive advantage in the growing peptide market.

🔬 What We Offer:

• Tirzepatide - Dual GIP/GLP-1 receptor agonist with proven research backing
• Semaglutide - Premium GLP-1 peptide solutions
• Custom formulations with Vitamin B12-100mcg API enhancement
• Complete private labeling with your brand identity

💼 Perfect for SMB Pharmaceutical Companies:

• Low minimum orders starting at 25,000 home kits
• Bulk API availability (5kg minimum for lyophilized powder)
• Activated NDC numbers upon order
• 30+ years of proven expertise in peptide research and manufacturing

📋 Complete Documentation Package:

• DMF (Drug Master File)
• Comprehensive Certificate of Analysis
• Sterility Reports & Stability Testing
• HRMS Analysis & Amino Acid Analysis
• CD Spectrometer molecular structure confirmation
• MSDS documentation

🚀 Why Choose Tirzepatide Pharma?

✅ FDA-compliant manufacturing according to Federal Food, Drug, and Cosmetic Act
✅ Complete rebranding capabilities for commercial distribution
✅ Comprehensive analytical testing with detailed reports
✅ Proven track record with 30+ years industry expertise
✅ Small business friendly minimum order quantities

Ready to Start Your Brand?

Contact our CDMO specialists today and discover how we can help your pharmaceutical business thrive in the competitive peptide market.

📧 cdmo@tirzepatidefirm.com

Transform your business with premium peptide solutions designed for success.

Tirzepatide Pharma Peptide Synthesis Technology 

Tirzepatide Pharma's ongoing research on the bioavailability of orally administered peptides compared to the subcutaneous route shows that 1 mg of peptide administered sublingually daily is equivalent to 5 mg administered subcutaneously weekly. The research aims to suggest alternative methods for alleviating injection site redness, pain, swelling, and total body chills, as well as muscular pain, triggered by subcutaneous administration in approximately 20% of the population.

Their sublingual peptide lozenges come in various forms, shapes, and sizes, ranging from mini capsules to tabs, each enhanced with 3mg Sodium salcaprozate (SNAC) to improve absorption. Sublingual administration was said to be comparable to subcutaneous administration, as neither undergoes enzymatic degradation by gastric acid, and they offer the sublingual peptide for research purposes only.

Tirzepatide Pharma is an FDA-registered API Peptide and monograph drug facility offering in-house Solid-Phase Peptide Synthesis utilizing cutting-edge peptide synthesizers, analytical-preparatory HPLC, and PEP Easy Clean purification technology for the highest purity. Provides pre-clinical investors with peptides for investigational drug trials. All peptides are Bachem-retested for purity, sequencing, amino acid identification, and mapping.

Our mission as a peptide pharmacology company is to discover modifications in the nucleotide structure that effectively modify the human genome, thereby elongating telomeres to enhance longevity and increase the average human lifespan to 140 years, while maintaining the youthful internal organs that sustain life.